Please enable JavaScript.
Coggle requires JavaScript to display documents.
hiv molecule
Human Immunodeficiency Virus (HIV), Protease Inhibitors…
Human Immunodeficiency Virus (HIV)
Political Frameworks
-
-
Funding
The Global Fund: The Global Fund invests more than US$5 billion a year to defeat HIV, TB and malaria and ensure a healthier, safer, more equitable future for all.
The U.S. President's Emergency Plan for AIDS Relief (PEPFAR): The US government has invested over $100 Billion to over 50 Countries to n the global HIV/AIDS response, saving over 25 million lives, preventing millions of HIV infections
-
Funding is integral to the development, implementation, and success of social policies related to HIV. It ensures that resources are available to combat the HIV epidemic effectively and provide care, support, and prevention to individuals
-
-
Treatments available
Gene therapy: Anti-HIV-1 gene therapy has several key goals: protecting hematopoietic progenitor cells from HIV-1, rendering susceptible cells resistant to the virus, inducing immunity to HIV-1 antigens, and inhibiting viral activity in specific organ target sites like the central nervous system. These objectives form a multifaceted approach to combat HIV-1 infection.
Broadly Neutralizing Antibodies: bnAbs prevent HIV-1 infection by selectively targeting vulnerable sites on the viral envelope (Env) protein that facilitates the entry of HIV.
Antiretroviral Therapy: Involves the daily administration of a combination of HIV medications, known as an HIV regimen, to manage and treat HIV infection. Typically, an individual's initial HIV regimen comprises a selection of three antiretroviral (ARV) drugs, chosen from a pool of at least seven different HIV drug classes.
-
-
Health Care Systems
-
Health systems play a role in shaping and executing HIV-related policies, encompassing guidelines for testing, treatment, and preventive approaches.
-
-
-
-